FLOSEAL HEMOSTATIC MATRIX 5 ML/10 ML KIT
FDA premarket approval P990009/S025 · decided 2010-01-07
Approval details
- PMA number
- P990009
- Supplement
- S025
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- FLOSEAL HEMOSTATIC MATRIX 5 ML/10 ML KIT
- Generic name
- Agent, absorbable hemostatic, collagen based
- Applicant
- Baxter Healthcare Corp
- Date received
- 2009-02-26
- Decision date
- 2010-01-07
- Days to decision
- 315 days
- Decision code
- APPR
- Product code
- LMF
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Round Lake, IL
- Statement
- APPROVAL FOR INCLUSION OF HUMAN THROMBIN THAT HAS BEEN TREATED WITH A SECOND VIRAL INACTIVATION STEP (SOLVENT DETERGENT PROCESS) IN THE FLOSEAL HEMOSTATIC MATRIX KIT AS WELL AS APPROVAL FOR ASSOCIATED LABELING CHANGES TO REFLECT THE ADDITIONAL VIRAL INACTIVATION STEP FOR THE THROMBIN COMPONENT.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| PrisMax System Version 2 (K190910) | Baxter Healthcare Corp | 2019-07-25 |
| PrisMax Control Unit (K163530) | Baxter Healthcare Corp | 2017-05-03 |
| ULTRAFUSE (K130531) | Baxter Healthcare Corp | 2014-04-08 |
| NEUTRAL LUER ACTIVATED DEVICE (ONE-LINK NEEDLE-FREE IV CONNECTOR) AND EXTENSION SETS (K132734) | Baxter Healthcare Corp | 2013-10-08 |
| LARGE BORE STOPCOCK WITH ROTATING MALE LUER LOCK/LARGE BORE STOPCOCK WITH EXTENSION SET, GANG LARGE BORE STOPCOCK MANIFO (K130245) | Baxter Healthcare Corp | 2013-03-01 |
| INTERLINK SYSTEM BURETROL SOLUTION SETS, INTERLINK SYSTEM BURETROL SOLUTION SETS, CONTINUED, CLEARLINK SYSTEM BURETROL S (K123874) | Baxter Healthcare Corp | 2013-01-10 |
| INTERLINK SYSTEM LEVER LOCK CANNULA WITH CHECK VALVE, SECONDARY MEDICATION SETS, SOLUTION SETS, CONTINU-FLO SOLUTION SET (K123868) | Baxter Healthcare Corp | 2013-01-08 |
| FLOWEASE [SUBCUTANEOUS] INFUSION SET (K121092) | Baxter Healthcare Corp | 2012-06-29 |